| Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p |
16 |
| Circular RNA ABCB10 promotes tumor progression and correlates with pejorative prognosis in clear cell renal cell carcinoma |
13 |
| Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis |
12 |
| Plasma long non-coding RNA HOTAIR as a potential biomarker for gastric cancer |
12 |
| High expression of Aurora-B is correlated with poor prognosis and drug resistance in non-small cell lung cancer |
10 |
| EGFR as a clinical marker in glioblastomas and other gliomas |
10 |
| Clinicopathological significance and prognostic role of tumor-infiltrating lymphocytes in colorectal cancer |
8 |
| Clinicopathological and molecular differences in colorectal cancer according to location |
7 |
| Long non-coding RNA PVT1 as a novel potential biomarker for predicting the prognosis of colorectal cancer |
7 |
| CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer |
6 |
| Clinical performance and utility of a NNMT-based urine test for bladder cancer |
6 |
| Performance of a MethyLight assay for methylated SFRP2 DNA detection in colorectal cancer tissue and serum |
5 |
| The role of serum neuron-specific enolase in patients with prostate cancer: a systematic review of the recent literature |
5 |
| The importance of hCG in human endometrial adenocarcinoma and breast cancer |
5 |
| Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients |
5 |
| Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: A meta-analysis |
5 |
| Clinical significance of tumor miR- miR- miR- and miR-106a as biomarkers in patients with osteosarcoma |
5 |
| MicroRNA-373 promotes the development of esophageal squamous cell carcinoma by targeting LATS2 and OXR1 |
5 |
| Correlation between PNPLA3 rs738409 polymorphism and hepatocellular carcinoma: a meta-analysis of 330 subjects |
4 |
| Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy |
4 |
| The serum level of CC chemokine ligand 18 correlates with the prognosis of non-small cell lung cancer |
4 |
| New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1 |
4 |
| Hsa_circ_0005075 promotes the proliferation and invasion of colorectal cancer cells |
4 |
| Relationship between GSTP1 rs1695 gene polymorphism and myelosuppression induced by platinum-based drugs: a meta-analysis |
4 |
| Clinical significance of fucosylated GP73 in the differential diagnosis of hepatocellular carcinoma |
4 |
| Prognostic roles of microRNA 143 and microRNA 145 in colorectal cancer: A meta-analysis |
4 |
| CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: A meta-analysis |
4 |
| Expression of PD-1/PD-L1 in head and neck squamous cell carcinoma and its clinical significance |
4 |
| iTRAQ-based proteomics reveals SOD2 as a potential salivary biomarker in liver cancer |
3 |
| Cell-free microRNAs as non-invasive biomarkers in glioma: a diagnostic meta-analysis |
3 |
| Clinical implications for pro-GRP in small cell lung cancer. A single center experience |
3 |
| Intratumoral immune cells expressing PD-1/PD-L1 and their prognostic implications in cancer: a meta-analysis |
3 |
| Prognostic value of hypoxia-inducible factor-1 alpha in nasopharyngeal carcinoma: a meta-analysis |
3 |
| Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients |
3 |
| Identification of circulating microRNAs as diagnostic biomarkers for ovarian cancer: A pooled analysis of individual studies |
3 |
| Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer |
3 |
| Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis |
3 |
| Expression of long intergenic non-coding RNA, regulator of reprogramming, and its prognostic value in patients with glioblastoma |
3 |
| Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer |
3 |
| Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection |
3 |
| Circulating tumor DNA as prognostic markers for late stage NSCLC with bone metastasis |
3 |
| Prognostic value of the Glasgow prognostic score in lung cancer: evidence from 10 studies |
3 |
| Deciphering the potential value of 5-fluorouracil metabolic enzymes in predicting prognosis and treatment response of colorectal cancer patients |
3 |
| BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis |
3 |
| The role of selected chemokines and their specific receptors in pancreatic cancer |
3 |
| Diagnostic value of CD56 immunohistochemistry in thyroid lesions |
3 |
| Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma |
2 |
| Changes of breast cancer staging when AJCC prognostic staging manual is used: a retrospective analysis of a Chinese cohort |
2 |
| Unfavorable clinical implications of peripheral blood CD44+and CD54+lymphocytes in patients with lung cancer undergoing chemotherapy |
2 |
| miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery |
2 |
